MARCHI, MARIO
 Distribuzione geografica
Continente #
EU - Europa 16.932
Totale 16.932
Nazione #
IT - Italia 16.932
Totale 16.932
Città #
Genova 12.860
Rapallo 1.889
Genoa 1.429
Vado Ligure 713
Bordighera 41
Totale 16.932
Nome #
Dangerous liaisons between beta-amyloid and cholinergic neurotransmission 147
Chronic nicotine exposure selectively activates a carrier-mediated release of endogenous glutamate and aspartate from rat hippocampal synaptosomes 146
In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens nerve terminals 145
Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F 144
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in rat hippocampus 143
Functional interaction between presynaptic nicotinic and D2 receptors on dopaminergic nerve endings of rat and mouse nucleus accumbens 137
Presynaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms 136
INTRACEREBRAL ADMINISTRATION OF L-KYNURENINE DECREASES N-METHYL-D-ASPARTATE RECEPTOR-MEDIATED PRODUCTION OF cGMP IN THE CEREBELLUM AND HIPPOCAMPUS OF UNANAESTHETIZED RATS SUBJECTED TO TRANSCEREBRAL MICRODIALYSIS 135
Presynaptic receptors modulating transmitter release: physiological and pharmacological aspects 133
Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training. 133
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 132
The activation of phosphatidylinositol turnover is not directly involved in the modulation of neurotransmitter release mediated by presynaptic muscarinic receptors 129
GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion 129
Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine 129
Salvinorin A modulates the neurotransmitters release from different mouse brain areas through presynaptic metabotropic receptors activation. 129
Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus 129
Aß influences nicotinic-stimulated release of both excitatory and inhibitory neurotransmitters in rat hippocampus 128
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release 128
Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release 126
CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings 125
Calcium-dependent [3H]acetylcholine release and muscarinic autoreceptors in rat cortical synaptosomes during development 124
3H-thymidine long survival autoradiography as a method for dating the time of neuronal origin in the chick embryo; the locus coeruleus and cerebellar Purkinje cells 122
Presynaptic receptors as potential targets of psychotropic drugs 122
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 121
Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system 121
Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors 120
Vasoactive intestinal polypeptide (VIP) potentiates the muscarinic stimulation of phosphoinositide turnover in rat cerebral cortex 118
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 117
Role of external and internal calcium on heterocarrier-mediated transmitter release 116
[3H]Pirenzepine binding in rat corpus striatum decreases after hemitransection of the nigro-striatal pathway 116
Dual Effect of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Glutamate, Aspartate and GABA in Rat Hippocampus 116
Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes 115
Acute β-Amyloid Administration Disrupts the Cholinergic Control of Dopamine Release in the Nucleus Accumbens 115
Studies on a possible functional coupling between presynaptic acetylcholinesterase and high-affinity choline uptake in the rat brain 114
Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration 114
Adaptation of presynaptic acetylcholine autoreceptors following long-term drug treatment 114
Effects of some rigid analogues of imipramine and amitriptyline on the uptake of noradrenaline, serotonin and choline in rat brain synaptosomes 114
Beta Amyloid and cholinergic system: old actors for new different roles 113
Sustainable production of biologically active molecules of marine based origin 113
Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat 113
Presynaptic regulation of acetylcholine release in the CNS 112
Development and aging of noradrenergic cell bodies and axon terminals in the chicken 110
Release of catecholamines, serotonin and acetylcholine from isolated brain tissue 109
Presynaptic nicotinic α7 and non-α7 receptors stimulate endogenous GABA release from rat hippocampal synaptosomes through two mechanisms of action. 109
Release-enhancing presynaptic muscarinic and nicotinic receptors coexist and interact on dopaminergic nerve endings of rat nucleus accumbens 109
Nicotinic receptors modulating ACh release in rat cortical synaptosomes: role of Ca2+ ions in their function and desensitization 108
Facilitation of [3H]acetylcholine and [3H]5-hydroxytryptamine release from rat cerebral cortex synaptosomes by a factor extracted from the skin of the Australian frog Pseudophryne coriacea 108
< i> In vitro exposure to nicotine modulate the function of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens 108
Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quasi-physiological" depolarization 107
Age-dependent changes in choline uptake of the chick iris 106
Prolonged nicotine exposure down-regulates presynaptic \NMDA\ receptors in dopaminergic terminals of the rat nucleus accumbens 106
Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals 106
P2X7 receptors exert a permissive role on the activation of release- enhancing presynaptic alpha7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals 105
Exposure to an enriched environment selectively increases the functional response of the pre-synaptic NMDA receptors which modulate noradrenaline release in mouse hippocampus 105
Pirenzepine-insensitive muscarinic autoreceptors regulate acetylcholine release in human neocortex 104
Modulation of endogenous and radiolabeled dopamine release by acetylcholine 104
Is acetylcholine release from striatal nerve endings regulated by muscarinic autoreceptors? 104
Cholinergic modulation of 3H-dopamine release from dendrosomes of rat substantia nigra 104
Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals 104
Presynaptic nicotinic receptors modulating neurotransmitter release in the Central Nervous System: functional interactions with other coexisting receptors 103
Dicyclomine- and pirenzepine-sensitive muscarinic receptors mediate inhibition of [3H]serotonin release in different rat brain areas 103
Intrastriatal kainic acid elicits functional supersensitivity of muscarinic receptors regulating dopamine release 103
Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes 102
Evidence of the involvement of nitric oxide in the oxiracetam-induced potentiation of glutamate release in rat hippocampal slices 101
Stimulus-selective neuromodulatory action of beta-amyloid 101
Norepinephrine levels in peripheral nerve terminals during development and aging 100
5-HT2A-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2Ato mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis 99
Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals 98
The functional recovery of damaged brain: the effect of GM1 monosialoganglioside 98
Age-dependent relationships among choline uptake, acetylcholine synthesis, acetylcholine release and muscarinic autoreceptors in rat brain synaptosomes 98
Modulation of sensitivity of central presynaptic autoreceptors 98
Muscarinic receptors mediating inhibition of GABA release in rat corpus striatum and their pharmacological characterization 97
Autoregulation of acetylcholine release in isolated hippocampal nerve endings 96
Neurotransmitter release as a functional test for the development of more selective CNS drugs 95
Dall'Arte degli Speziali alla Scienza del Farmaco a Genova 95
Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release 95
Regulation of dopamine release by muscarinic receptors 95
Mechanisms underlying the modulation of dopamine release through presynaptic muscarinic receptors 95
Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex 95
Effects of oxiracetam on neurotransmitter release from rat hippocampus slices and synaptosomes 93
Changes of neurotransmitter release in the old rat brain and effects of phosphatidylserine treatment 92
Heterogenenity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain 91
Presynaptic cholinergic mechanisms in human cerebral cortex of adult and aged patients 91
Presynaptic modulation of cholinergic neurotransmission 90
A new specific neuronal modulatory effect of nicotine: the functional cross talk between nicotinic and glutamate receptors 90
Characterization of GABAA receptors expressed in glial cell membranes of adult mouse neorcortex using a Xenopus oocyte microtransplantation expression system 90
Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 89
null 89
Isolation of hydroxyoctaprenyl-1’,4’-hydroquinone, a new octaprenylhydroquinone from the marine sponge Sarcotragus spinosulus and evaluation of its pharmacological activity on acetylcholine and glutamate release in the rat Central Nervous System. 89
NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment 88
β-amyloid differently modulates the function of nAChRs which stimulate the release of glutamate, aspartate, glycine and GABA in rat hippocampus 88
Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals 88
Norepinephrine uptake in aging adrenergic nerve terminals 88
Increased uptake of [3H]choline by rat superior cervical ganglion: an effect of dexamethasone 88
Enhancement of glycine release from human brain cortex by acetylcholine acting at M4 muscarinic receptors 87
Presynaptic muscarinic autoreceptors: changes of sensitivity during long-term drug treatment 87
Pharmacological characterization of the presynaptic muscarinic autoreceptors regulating acetylcholine release from rat cortical synaptosomes 87
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease 87
Peripheral and central adrenergic neurons: differences during the aging process 87
Beta amyloid a disease target or a synaptic regulator affecting age-related neurotransmitter changes 86
Totale 10.881
Categoria #
all - tutte 48.558
article - articoli 33.092
book - libri 0
conference - conferenze 8.896
curatela - curatele 216
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.354
Totale 97.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.714 0 0 0 0 392 386 634 233 380 845 619 225
2020/2021936 45 104 51 71 48 85 41 89 136 92 76 98
2021/20222.249 47 177 148 330 87 144 129 527 50 220 74 316
2022/20232.274 241 149 34 165 416 365 24 189 418 11 246 16
2023/20241.046 51 146 28 144 100 232 38 55 53 44 35 120
2024/2025760 77 236 74 200 173 0 0 0 0 0 0 0
Totale 17.078